NATCO Pharma Limited’s (NATCOPHARM) Moving Averages Convergence Divergence (MACD) indicator is -0.71, suggesting NATCO Pharma Limited is a Sell.
NATCO Pharma Limited’s (NATCOPHARM) 20-Day exponential moving average is 799.81, while NATCO Pharma Limited’s (NATCOPHARM) share price is ₹812.25, making it a Buy.
NATCO Pharma Limited’s (NATCOPHARM) 50-Day exponential moving average is 816.49, while NATCO Pharma Limited’s (NATCOPHARM) share price is ₹812.25, making it a Sell.
NATCO Pharma Limited’s (NATCOPHARM) 10-Day exponential moving average is 801.83, while NATCO Pharma Limited’s (NATCOPHARM) share price is ₹812.25, making it a Buy.
NATCO Pharma Limited’s (NATCOPHARM) 100-Day exponential moving average is 850.31, while NATCO Pharma Limited’s (NATCOPHARM) share price is ₹812.25, making it a Sell.
NATCO Pharma Limited’s (NATCOPHARM) stock price is ₹812.25 and NATCO Pharma Limited’s (NATCOPHARM) 50-day simple moving average is 807.42, creating a Buy signal.
NATCO Pharma Limited’s (NATCOPHARM) stock price is ₹812.25 and NATCO Pharma Limited’s (NATCOPHARM) 100-day simple moving average is 859.21, creating a Sell signal.
NATCO Pharma Limited’s (NATCOPHARM) stock price is ₹812.25 and NATCO Pharma Limited’s (NATCOPHARM) 200-day simple moving average is 918.58, creating a Sell signal.